Recent reports from several developed countries have documented a resurgence of biliru-bin encephalopathy causing both healthcare and forensic issues. For these reasons, many national pediatric societies have issued recommendations on the diagnosis and the treatment of clinically significant neonatal hyperbilirubinemia. The differences among individual national documents may have an impact on neonatal healthcare. This paper shortly reviews the advantages and the shortcom-ings of the main international guidelines with a focus on the available evidence.
Neonatal hyperbilirubinemia: An updated appraisal of national guidelines / Capasso, L.; Palma, M.; Coppola, C.; Salome, S.; Esposito, V.; Grappone, L.; Raimondi, F.. - In: CURRENT PEDIATRIC REVIEWS. - ISSN 1573-3963. - 16:4(2020), pp. 298-306. [10.2174/1573396316666200928101553]
Neonatal hyperbilirubinemia: An updated appraisal of national guidelines
Capasso L.;Raimondi F.
2020
Abstract
Recent reports from several developed countries have documented a resurgence of biliru-bin encephalopathy causing both healthcare and forensic issues. For these reasons, many national pediatric societies have issued recommendations on the diagnosis and the treatment of clinically significant neonatal hyperbilirubinemia. The differences among individual national documents may have an impact on neonatal healthcare. This paper shortly reviews the advantages and the shortcom-ings of the main international guidelines with a focus on the available evidence.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
